EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. GalleEuropean Association for the Study of the Liver (EASL), The EASL Building -Home of Hepatology, 7 rue Daubin, CH 1203 Geneva, SwitzerlandAlejandro FornerEuropean Association for the Study of the Liver (EASL), The EASL Building -Home of Hepatology, 7 rue Daubin, CH 1203 Geneva, SwitzerlandJosep M. LlovetEuropean Association for the Study of the Liver (EASL), The EASL Building -Home of Hepatology, 7 rue Daubin, CH 1203 Geneva, SwitzerlandVincenzo MazzaferroEuropean Association for the Study of the Liver (EASL), The EASL Building -Home of Hepatology, 7 rue Daubin, CH 1203 Geneva, SwitzerlandFabio PiscagliaEuropean Association for the Study of the Liver (EASL), The EASL Building -Home of Hepatology, 7 rue Daubin, CH 1203 Geneva, SwitzerlandJean‐Luc RaoulEuropean Association for the Study of the Liver (EASL), The EASL Building -Home of Hepatology, 7 rue Daubin, CH 1203 Geneva, SwitzerlandPeter SchirmacherEuropean Association for the Study of the Liver (EASL), The EASL Building -Home of Hepatology, 7 rue Daubin, CH 1203 Geneva, SwitzerlandValérie VilgrainEuropean Association for the Study of the Liver (EASL), The EASL Building -Home of Hepatology, 7 rue Daubin, CH 1203 Geneva, Switzerland
2018en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
5 та иқтибос0 та фойдаланилган манба